This study identifies the Kcnma1 gene and a specific 50-amino acid splice insert as the molecular basis for the mitochondrial BKCa channel, which mediates cardioprotection against ischemia.
The large-conductance Ca 2+ - and voltage-activated K + channel (BK Ca, MaxiK), which is encoded by the Kcnma1 gene, is generally expressed at the plasma membrane of excitable and nonexcitable cells. However, in adult cardiomyocytes, a BK Ca -like channel activity has been reported in the mitochondria but not at the plasma membrane. The putative opening of this channel with the BK Ca agonist, NS1619, protects the heart from ischemic insult. However, the molecular origin of mitochondrial BK Ca (mitoBK Ca ) is unknown because its linkage to Kcnma1 has been questioned on biochemical and molecular grounds. Here, we unequivocally demonstrate that the molecular correlate of mitoBK Ca is the Kcnma1 gene, which produces a protein that migrates at ∼140 kDa and arranges in clusters of ∼50 nm in purified mitochondria. Physiological experiments further support the origin of mitoBK Ca as a Kcnma1 product because NS1619-mediated cardioprotection was absent in Kcnma1 knockout mice. Finally, BK Ca transcript analysis and expression in adult cardiomyocytes led to the discovery of a 50-aa C-terminal splice insert as essential for the mitochondrial targeting of mitoBK Ca .
Singh et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: